- Gao J, Chen J, De Domenico I, Koeller DM, Harding CO, Fleming RE, et al. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood. 2010;115(16):3374-81.
- Camaschella C, Roetto A, Calì A, De Gobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25(1):14-5.
- del-Castillo-Rueda A, Moreno-Carralero M-I, Cuadrado-Grande N, Álvarez-Sala-Walther L-A, Enríquez-de-Salamanca R, Méndez M, et al. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Gene. 2012;508(1):15-20.
- Ding K, Shameer K, Jouni H, Masys DR, Jarvik GP, Kho AN, et al., editors. Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits. Mayo Clinic Proceedings; 2012.
- Silvestri L, Nai A, Pagani A, Camaschella C. The extrahepatic role of TFR2 in iron homeostasis. Front Pharmacol. 2014;5:93.
- Zarghamian P, Azarkeivan A, Arabkhazaeli A, Mardani A, Shahabi M. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy. BMC Med Gen. 2020;21(1):75.
- Drake SF, Morgan EH, Herbison CE, Delima R, Graham RM, Chua AC, et al. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest. Liver Physiol. 2007;292(1):G323-G8.
- Piperno A, Pelucchi S, Mariani R. Inherited iron overload disorders. Transl Gastroenterol Hepatol. 2020;5:25.
- Schmidt PJ, Fitzgerald K, Butler JS, Fleming MD. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model. Am J Hematol. 2021;96(2):251-7.
- Cappellini MD. Exjade®(deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag. 2007;3(2):291.
- Sun S-Y, Guo Y-H, Sun Z-M, Wu Y-H, Li M-X. Analysis of HFE and Non-HFE mutations in a Tibet cohort with iron overload. Zhongguo shi yan xue ye xue za zhi. 2019;27(2):618-22.
- Santos P, Cancado R, Terada C, Rostelato S, Gonzales I, Hirata R, et al. HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol. 2010;43:107-14.
- Aguilar-Martinez P, Esculié-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved J-F. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Blood Cells Mol Dis. 2001;27(1):290-3.
- Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood. 2005;105(1):376-81.
- Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. PNAS. 2002;99(16):10653-8.
16. Piperno A, Roetto A, Mariani R, Pelucchi S, Corengia C, Daraio F, et al. Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica. 2004;89(3):359-60.
|